Ellomay Capital Ltd. Clarifies Prospectus Supplement

Ticker: ELLO · Form: 6-K · Filed: Jul 2, 2025 · CIK: 946394

Ellomay Capital LTD. 6-K Filing Summary
FieldDetail
CompanyEllomay Capital LTD. (ELLO)
Form Type6-K
Filed DateJul 2, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: clarification, prospectus, investor-relations

TL;DR

Ellomay Capital clarifies its July 1st prospectus supplement after investor questions.

AI Summary

Ellomay Capital Ltd. issued a clarification on July 2, 2025, regarding its Prospectus Supplement published on July 1, 2025. This clarification was prompted by investor inquiries following the supplement's release.

Why It Matters

This filing provides important context for investors who may have questions about the recent Prospectus Supplement, ensuring transparency in the company's financial communications.

Risk Assessment

Risk Level: low — The filing is a routine clarification and does not introduce new financial risks or significant operational changes.

Key Players & Entities

FAQ

What is the purpose of this 6-K filing?

This 6-K filing serves as a clarification by Ellomay Capital Ltd. in response to investor inquiries following the publication of its Prospectus Supplement on July 1, 2025.

When was the Prospectus Supplement published?

The Prospectus Supplement was published on July 1, 2025.

What prompted this clarification?

Investor inquiries received after the publication of the Prospectus Supplement prompted this clarification.

What is the company's principal executive office address?

The company's principal executive office is located at 18 Rothschild Blvd., Tel Aviv 6688121, Israel.

Does Ellomay Capital Ltd. file annual reports under Form 20-F or 40-F?

Ellomay Capital Ltd. files annual reports under Form 20-F.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on July 2, 2025 regarding Ellomay Capital Ltd. (ELLO).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing